Details
Stereochemistry | RACEMIC |
Molecular Formula | C10H15NO |
Molecular Weight | 165.2322 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC(C)CC1=CC=C(O)C=C1
InChI
InChIKey=SBUQZKJEOOQSBV-UHFFFAOYSA-N
InChI=1S/C10H15NO/c1-8(11-2)7-9-3-5-10(12)6-4-9/h3-6,8,11-12H,7H2,1-2H3
Molecular Formula | C10H15NO |
Molecular Weight | 165.2322 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Pholedrine is a hydroxymethylamphetamine. It is a sympathimimetric drug of low toxicity, which is of great value in conditions of hypotonia, collapse, and circulatory depression. Pholedrine was reported on in 1937 by several investigators, who described its vasopressor action in animals as more potent than that of ephedrine. The drug is grouped with hydroxyamphetamine because of its similarity in structure and hemodynamic pattern. Pholedrine, in small doses, potentiates epinephrine, but in large doses blocks its pressor effect. Pholedrine applied as eye-drops produces mydriasis that is greatly attenuated by guanethidine pretreatment and diminished in patients with postganglionic sympathetic nerve lesions. It might be used to diagnose Horner's syndrome.
Approval Year
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
60.7 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/10348201/ |
40 mg single, oral dose: 40 mg route of administration: Oral experiment type: SINGLE co-administered: |
PHOLEDRINE plasma | Homo sapiens population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:38:03 GMT 2023
by
admin
on
Fri Dec 15 16:38:03 GMT 2023
|
Record UNII |
AY28O44JGD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29747
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB09796MIG
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | |||
|
PHOLEDRINE
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | |||
|
C005877
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | |||
|
AY28O44JGD
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | |||
|
m8712
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | Merck Index | ||
|
4190
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | |||
|
4655
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | |||
|
100000082448
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | |||
|
C73067
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | |||
|
370-14-9
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | |||
|
206-725-0
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | |||
|
33432
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL2008672
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | |||
|
DTXSID70861908
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY | |||
|
3463
Created by
admin on Fri Dec 15 16:38:03 GMT 2023 , Edited by admin on Fri Dec 15 16:38:03 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |